HAIP Chemo Offers OS Advantage in Advanced Intrahepatic Cholangiocarcinoma
One in three trial patients still alive at 3 years after hepatic arterial infusion pump treatment
Source: medpagetoday.com
Stay updated with breaking news from Benjamin Schlechter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
One in three trial patients still alive at 3 years after hepatic arterial infusion pump treatment
/PRNewswire/ -- Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the...